Vivus Initiated at Buy and 3 Analyst-Initiated Shares to Watch

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on September 24th.

Alexion Pharma (NASDAQ:ALXN): Canaccord Genuity initiated coverage of this company with a rating of Buy and a price target of $115 >> $132.

Don’t Miss: Can Apple Hit This Magic Number?

CBS (NYSE:CBS): The Benchmark Company initiated coverage of this company with a rating of Buy and a price target of $39 >> $44.

Vivus (NASDAQ:VVUS): Needham initiated coverage of this company with a rating of Buy and a price target of $38 >> $32.

Salesforce.com (NYSE:CRM): Needham initiated coverage of this company with a rating of Buy and a price target of $160 >> $180.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>